RNS Number : 9793F
Aminex PLC
13 July 2023
 

13 July 2023

 

Aminex plc

("Aminex" or "the Company")

 

                                            Result of Annual General Meeting          

Aminex PLC announces that all the resolutions put to shareholders at the Annual General Meeting ("AGM") of the Company held earlier today were duly passed.  Each of the resolutions put to the AGM was voted on by way of a poll and the results are set out below.   

 

 

Resolution

Total

For

Against

Vote withheld*

1

To receive and consider the Statement of Accounts for the year ended 31 December 2022

1,198,170,716

1,198,161,032

 (100.00%)

9,684

(0.00%)

36,771

2

To re-elect Tom Mackay

1,198,173,900

1,196,957,697

(99.90%)

 1,216,203

(0.10%)

33,587

4

To authorise Directors to fix Auditor's remuneration

1,198,173,916

1,196,983,188

 (99.90%)

1,190,728

 (0.10%)

33,571

5

To authorise Directors to allot relevant securities

1,198,166,209

1,196,917,632

(99.90%)

 1,248,577

(0.10%)

33,833

6

To authorise Directors to allot equity securities for cash

1,198,198,663

1,195,349,667

(99.76%)

2,848,996

(0.24%)

8,824

 

*A vote withheld is not a vote in law and is not counted in the calculation of the proportion of votes for or against a resolution. 

 

 

For further information:

 


Aminex PLC

+44 20 3355 9909

Charles Santos, Executive Chairman




Davy

+353 1 679 6363

Brian Garrahy



 

Shard Capital Partners

+44 20 7186 9952

Damon Heath

 

 

 



 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGSFIFIDEDSEEW